REVVITY, INC Proceeds from Collection of Notes Receivable
REVVITY, INC (RVTY) reported Proceeds from Collection of Notes Receivable of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2024-02-27
- REVVITY, INC proceeds from collection of notes receivable for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- REVVITY, INC proceeds from collection of notes receivable for fiscal 2023 was $8.89M.
- REVVITY, INC proceeds from collection of notes receivable for fiscal 2022 was $0.00.
- REVVITY, INC proceeds from collection of notes receivable for fiscal 2021 was $0.00.
| Period end | Proceeds from Collection of Notes Receivable 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2023-01-01 | $8.89M 10-K · filed 2024-02-27 |
| 2022-01-02 | $0.00 10-K · filed 2024-02-27 |
| 2021-01-03 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |